Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Echinacea Purpurea (Cichoric Acid).
Echinacea purpurea functions as an immunomodulator by stimulating phagocytic activity and enhancing cytokine production through the activation of cannabinoid receptor type 2 (CB2) and toll-like receptor pathways.
5281764
474.4 g/mol
2
(2R,3R)-2,3-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]butanedioic acid
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Echinacea Purpurea (Cichoric Acid) across standard consumer modalities.
The hygroscopic nature of concentrated extracts requires moisture-resistant HPMC shells to prevent clumping and degradation of phenolic compounds.
High concentrations of alkylamides can cause a distinct tingling sensation (paresthesia) on the tongue, necessitating flavor masking or encapsulation to maintain palatability.
The high therapeutic dose required for effective immunomodulation often exceeds the 20-30mg payload capacity of standard thin-film polymer matrices.
Ready to launch a product featuring Echinacea Purpurea (Cichoric Acid)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Echinacea Purpurea (Cichoric Acid) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Echinacea Purpurea (Cichoric Acid) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation